Accenture initiated at BofA/MerrillACN coverage initiated with a Buy rating and $58 price target. Well-positioned and plenty of runway, Bank of America/Merrill Lynch said.
Berry Petroleum upgraded at KeybancBRY was upgraded from Hold to Buy, Keybanc said. $42 price target. Company has attractive oil assets.
Concur Technologies rated new Neutral at GoldmanCoverage of CNQR was started with a Neutral rating, Goldman Sachs said. Company has strong margins, but already trades at a premium valuation.
Coinstar downgraded at Thomas WeiselCSTR downgraded to Market Weight from Overweight as the market is factoring too much upside, Thomas Weisel said. Price target lifted to $38 from $26.
FPL Group upgraded at BofA/MerrillFPL upgraded to Buy from Neutral. Only diversified utility that can produce positive earnings growth next 3-4 years, Bank of America/Merrill Lynch said. Price target lifted to $54 from $51.
Petrohawk Energy upgraded at FBRHK was upgraded from Market Perform to Outperform, FBR Capital Markets said. $30 price target. Company is closing its funding gap with asset sales and lower CapEx spending.
Interpublic upgraded at ArgusIPG was upgraded from Hold to Buy, Argus Research said. $12 price target. Consumer economy is rebounding and the company should benefit from higher advertising spending.
Microchip Technology upgraded at UBSMCHP was upgraded from Neutral to Buy, UBS said. $34 price target. Estimates also raised, as the company is positioned well coming out of the recent industry downturn.
Monster Worldwide upgraded at Credit SuisseMWW upgraded to Outperform from Neutral on improving labor conditions and rising operating metrics, Credit Suisse said. Price target jumped to $22 from $15. 2009 and 2010 EPS estimates lifted to 35 cents and 3 cents, respectively.
Protective Life Corp downgraded to BofA/MerrillPL downgraded to Neutral from Buy on valuation, Bank of America/Merrill Lynch said. Price target lifted to $25 from $23.
R.R. Donnelley rated new Outperform at BairdRRD was initiated with an Outperform rating, Robert Baird said. $27 price target. Company is positioned to benefit from a cyclical recovery in advertising spending.
SuccessFactors upgraded at JanneySFSF was upgraded to Buy, Janney Montgomery said. $24 price target. Sales and margins have improved from trough numbers in the third quarter.
Sensata Technologies initiated at BarclaysST initiated at Barclays with an Overweight rating and $24 price target. Visibility to growth, healthy margins, and solid cash generation, analysts said.
Waddell & Reed Financial downgraded at BofA/MerrillWDR downgraded to Neutral from Buy on valuation, Bank of America/Merrill Lynch said. Price target raised to $40 from $36.
Zions Bancorporation numbers boosted at FBRShares of ZION now seen reaching $27, according to FBR Capital Markets. Estimates also raised, as the credit turnaround is gaining momentum. Outperform rating.
Zions Bancorporation upgraded at KBWZION was upgraded from Underperform to Market Perform, Keefe, Bruyette & Woods said. $25 price target. Estimates also raised, as the company is seeing lower net charge-offs.
ACI estimates were raised through 2012, FBR Capital Markets said. Company had a weak quarter, but is seeing higher met coal volumes. Outperform rating and $39 price target.
Atheros estimates, target boosted at FBR
Shares of ATHR now seen reaching $43, FBR Capital Markets said. Company is seeing higher demand and gaining market share. Market Perform rating.
Atheros estimates, target boosted at FBRShares of ATHR now seen reaching $43, FBR Capital Markets said. Company is seeing higher demand and gaining market share. Market Perform rating.
Citigroup estimates, target increased at UBSShares of C now seen reaching $5, UBS said. Estimates also raised, even though numbers should tail off from a strong first quarter. Neutral rating.
Citigroup target, estimates raised at BarclaysC price target increased a dollar to $6 after mixed 1Q10 results, Barclays said. 2010 and 2011 EPS estimates lifted to $0.35 and $0.45, respectively. Overweight rating.
Corning target, estimates raised at BarclaysGLW price target increased a dollar to $24. Expecting a beat and raise, Barclays said. 2010 and 2011 EPS estimates increased to $1.85 and $2.00, respectively.
Halliburton estimates, target raised at GoldmanHAL estimates were increased through 2012, Goldman Sachs said. Company is seeing higher margins in North America and International growth is around the corner. Buy rating and new $43 price target.
Home Depot numbers raised at FBRShares of HD now seen reaching $40, according to FBR Capital Markets. Estimates also increased, as checks suggest the company is seeing higher sales trends. Outperform rating.
IBM numbers boosted at BarclaysIBM 2010 and 2011 EPS estimates raised to $11.22 and $12.40 as 1Q10 was in line with expectations, Barclays said. Maintain Equal Weight rating and $145 price target.
IBM estimates boosted at GoldmanIBM estimates were upped through 2012, according to Goldman Sachs. Company is seeing higher sales, but currency trends are adding to costs. Neutral rating and $140 price target.
Eli Lilly numbers cut at BarclaysLLY 2010 and 2011 EPS estimates sunk to $4.49 and $4.29, respectively. $0.35 negative impact to EPS from Health Care Reform, Barclays said. Maintain Equal Weight rating and $39 price target.
Eli Lilly estimates lowered at GoldmanLLY estimates were cut through 2012, Goldman Sachs said. Company will see lower sales, given healthcare reform. Sell rating and $34 price target.
Lowe's estimates, target boosted at FBRLOW estimates were raised through 2011, FBR Capital Markets said. Company is likely seeing better sales trends. Outperform rating and new $30 price target.
Lam Research numbers boosted at UBSLRCX estimates were raised through 2011, UBS said. Company should benefit from higher memory CapEx spending. Buy rating and new $52 price target.
MGM Mirage added to Conviction Buy list at GoldmanMGM was added to the Conviction Buy list, Goldman Sachs said. Decline following the convertible offering has created an attractive buying opportunity. $17.50 price target.
Monsanto target, estimates cut at Credit SuisseMON price target sunk to $72 from $86 on higher competition, Credit Suisse said. 2010 and 2011 EPS estimates trimmed to $3.13 and $3.58, respectively. Maintain Neutral rating.
M&T Bank estimates, target upped at FBRMTB estimates were increased through 2011, FBR Capital Markets said. Company is seeing lower credit costs and improving capital ratios. Market Perform rating and new $82 price target.
Standard Pacific numbers boosted at UBSSPF estimates were raised through 2011, UBS said. Company is finding lots at attractive prices and community growth should accelerate. Neutral rating and new $5.25 price target.
Trina Solar Limited target higher, estimates mixed at BarclaysTSL price target increased to $27 from $25 as 2H10 estimates appear conservative, Barclays said. 2010 EPS estimates cut to $2.49, 2011 EPS estimate raised to $2.04. Equal Weight rating.
United Technologies target upped at UBSShares of UTX now seen reaching $82, according to UBS. Company has lagged its peers, but should catch up as the economic recovery continues. Buy rating.
Werner Enterprises estimates lowered at FBRWERN estimates were reduced through 2011, FBR Capital Markets said. Company is seeing softer pricing. Market Perform rating and $25 price target.
